ChemPartner

🚀 Exciting News from @ChemPartner – We’re Expanding in the UK! We’re proud to announce the opening of our 𝗻𝗲𝘄 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝘀𝗶𝘁𝗲 𝗮𝘁 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆 𝗣𝗮𝗿𝗸 𝗶𝗻 𝗦𝗮𝗻𝗱𝘄𝗶𝗰𝗵, one of the UK’s leading science and innovation hubs, just an hour from London!

Join @ChemPartner this month at one of the year’s biggest events in science, 𝗔𝗖𝗦 𝗦𝗽𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟲, now celebrating its 150th year, in Atlanta, GA! #ACS150 𝗟𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲👉 chempartner.com/resources/news…

Interested in strategies for overcoming resistance and off-target toxicity in next-generation #ADC's? Attend @ChemPartner's 𝗚𝗘𝗡 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝗔𝗗𝗖'𝘀 later this month! 𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗻𝗼𝘄👉 chempartner.com/resources/webi… #BioPharma #Oncology #CRO

#𝗪𝗼𝗿𝗹𝗱𝗔𝗗𝗖𝗟𝗼𝗻𝗱𝗼𝗻 𝗵𝗮𝘀 𝘄𝗿𝗮𝗽𝗽𝗲𝗱 It was great diving into thoughtful conversations about where #ADC science is heading next. Let’s keep the discussions going! 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗼𝘂𝗿 𝗽𝗼𝘀𝘁𝗲𝗿👉 chempartner.com/resources/news…

We're heading to #𝗪𝗼𝗿𝗹𝗱𝗔𝗗𝗖𝗟𝗼𝗻𝗱𝗼𝗻 𝟮𝟬𝟮𝟲 next week to talk about what's next in #ADC innovation. Stop by Booth 35 for a conversation on how diverse modality ADC design is pushing the boundaries of therapeutic efficacy. #CRO

💡40-70% of new molecules flag hERG liability → many promising compounds dropped early due to false alarms in traditional assays. 🚨At @ChemPartner, we deliver validated CiPA to spot true risks early, align w/ ICH E14/S7B & build stronger INDs.

@ChemPartner's updated visual identity comes with a faster, smarter chempartner.com. 🚀Built for scientists: instant clarity, intuitive navigation across the discovery pipeline, and direct access to experts worldwide. Catalytic innovation - on your terms. #BioPharma

Tumor heterogeneity is why ADCs fail: You have perfect payload, optimized linker, clear MoA. ❌And the tumor adapts! Dual-payload ADCs (dpADCs) widen cytotoxic coverage-but require perfect DAR optimization. 👉Read more on our blog: chempartner.com/resources/blog… #ADC #Oncology #DAR

Why do cytokine receptor programs stall after strong early data? Pleiotropic biology + siloed assays can hide risks downstream. Our cytokine receptor platform integrates 60+ assays & in vivo models to elucidate MoAs early. #autoimmune #psoriasis #ibd chempartner.com/resources/blog…

✨We celebrate a new chapter for @ChemPartner - one grounded in rigorous science🔬, global collaboration, and a shared purpose to move discovery forward.🚀 With 2,000+ scientists🧑‍🔬across continents, we bring proven science and adaptive collaboration. #BioPharma #BioTech

🚀 @ChemPartner unveils an updated visual identity and digital experience - sharpening how we express what’s always defined us: rigorous science, adaptive collaboration, and partnership-driven discovery with one mission: faster, clearer answers. 🔗prnewswire.com/news-releases/…

Missed the webinar on EEG Analysis and Animal Behavior in CNS Drug Development by Dr. Ruiben Feng? Watch the recording on demand here: chempartner.com/webinars/ #Neuroscience #DrugDevelopment

Haven’t seen our latest poster on molecular glue degraders? Take a look! chempartner.com/wp-content/upl… #MolecularGlueDegraders #ProteinScience

🚨Searching for dispersed tumor model data has never been easier. Sign up for ChemPartner's new Biology Database for free and start searching: database.chempartner.com #TumorModels #OncologyResearch

Want to better understand the paradigm shift occurring in Chinese CROs and the impact on drug development? Join ChemPartner’s VP of Biology and Pharmacology, Dr. Yinfei Yin, at the prestigious Medical Industry Innovation Forum in Tokyo. Register here: chempartner.com/events/medical…

Curious about the rapid single B cell cloning workflow we are using to discover rabbit antibodies? Watch the webinar given by our Director of Biologics Discovery, Andreas Loos, PhD: xtalks.com/webinars/a-rap… #AntibodyDiscovery #SingleCellCloning

Get more effective drugs and therapies through rabbit antibodies - known for their unique antibody structure and diverse epitope recognition capabilities. Check out our latest data on rabbit antibodies using our rapid single B-cell cloning workflow. chempartner.com/publications/

🚨 BIG NEWS! We are officially launching our highly anticipated Biology Database. This innovative platform offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs. Read the press release: bit.ly/3RQuQw6 #OncologyResearch

However you celebrate this holiday season, all of us at ChemPartner wish you much joy and a bright new year! ❄ #HappyHolidays2023

Pre-book a time to meet with our experts next month at the 12th annual Tumour Models in London: chempartner.com/events/tumour-… #TumourModelsLondon #Oncology #PDX #InVivo